Non-clear cell renal cell carcinoma (NCCRCC)

Clinical trials for Non-clear cell renal cell carcinoma (NCCRCC) explained in plain language.

Never miss a new study

Get alerted when new Non-clear cell renal cell carcinoma (NCCRCC) trials appear

Sign up with your email to follow new studies for Non-clear cell renal cell carcinoma (NCCRCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 2 Not yet finished but already full! 1

Cancer patients to continue promising treatments in major extension trial

Disease control By invitation only

This long-term extension study offers continued access to several cancer drugs—including cabozantinib, atezolizumab, and nivolumab—for up to 5,000 patients who benefited from them in earlier Exelixis-sponsored trials. The study focuses on monitoring safety and ongoing clinical be…

Matched conditions: NON-CLEAR CELL RENAL CELL CARCINOMA (NCCRCC)

Phase 3 • Sponsor: Exelixis • Aim: Disease control

Last updated Aug 20, 2026 00:00 UTC

Non-clear cell renal cell carcinoma (NCCRCC)

Get alerted when new Non-clear cell renal cell carcinoma (NCCRCC) trials appear

Cancer patients to continue promising treatments in major extension trial